Lehmann Maupin and Gallery Wendi Norris to Collaborate on Two-Part Exhibition Pairing Leonora Carrington and Cecilia Vicuña
The first part will open in New York in November, followed by the second part in San Francisco in January.
Social Security Benefits Could Rise in 2027 as Inflation Shapes the Upcoming COLA
We’ll know for sure in just a few days.
SCHD vs. VYM: Which Dividend ETF Deserves a Spot in Your Income Portfolio?
There’s always more to the matter than mere yield (although dividend yields are still important).
Docebo’s 2026 Outlook: AI-Driven Software Platform Scales Capital Efficiency
This under-the-radar enterprise software stock boasts a Superscore of 83 from our Hidden Gems Primary database, part of The Motley Fool’s Moneyball Database system. Here’s why.
Chewy vs. Coupang: Which Consumer Stock Is a Better Buy in 2026?
Chewy trades at a fraction of Coupang’s valuation multiple, but one faces Amazon’s shadow while the other grapples with regulatory headwinds and a major data breach.
Got $500? 2 No-Brainer Energy Dividend Stocks to Buy Right Now, Starting With a Huge 6% Yield.
Every investor should have exposure to energy, but with oil prices high, you need to be selective if you are looking for reliable dividends.
AI Bubble or Not, Warren Buffett Would Buy This Vanguard Index Fund
The S&P 500 is trading at historical valuations, making some investors nervous a stock market crash is on the way.
Oppenheimer Thinks Viking Therapeutics Stock Can Soar to $120. Here’s the Math Behind the Ultra-Bullish Call.
Oppenheimer raised Viking Therapeutics’ price target to $120, citing strong trial data, and an improving probability of success for its key drug.
Should You Buy Micron Stock in October?
What comes next for this memory hardware giant?
Social Security’s 2027 COLA Should Be Among the Largest in 35 Years, Thanks to Trumpflation and a First-of-Its-Kind Catalyst
Independent estimates call for Social Security benefits to rise by 3.5% in 2027 — but this isn’t the biggest story.
Own Clorox by Oct. 28 to Qualify for Its Next Dividend (Yielding 6%). Here’s How Many Shares You’d Need for $5,000 in Yearly Dividends.
Clorox has an above-average dividend yield.
Nvidia and Micron Technology Just Received Some Very Bad News From an Unlikely Place
Australian investors just rejected one of the country’s biggest artificial intelligence companies.
Vanguard’s S&P 500 Fund Has Raised Its Payout 71% Since 2016. Its Yield Has Nearly Halved.
Why does $10,000 buy around half the yearly income it did in 2016?
Prediction: IonQ Stock Will Double by the End of 2027
IonQ has a major product launch coming up in 2027.
Popular weight loss drugs linked to a surprising fingernail problem
Popular GLP-1 weight loss drugs, such as Ozempic and Wegovy, have been linked to unexpectedly high rates of nail detachment, hair loss, and scalp inflammation, with some problems occurring several times more frequently among users. Researchers found th…
Bloom Energy Stock Has Fallen 20% or More 5 Times Since September 2025. It Recovered From 4 Within Weeks.
The fuel cell maker had the largest quarter in its history. Why hasn’t the stock rebounded this time?
Scientists find hidden driver of aging and a simple amino acid that fights memory loss in mice
Scientists discovered that declining levels of a protein called Menin may help drive aging, and restoring it in older mice reversed several age-related changes in just 30 days. Even more surprisingly, supplementing with a simple amino acid called D-ser…
These 2 AI Stocks Have Stumbled. Now They May Soar Nearly 75%, According to Wall Street.
These companies are delivering record revenue.
Heed Warren Buffett’s Advice: The Time to Be Fearful When Others Are Greedy Has Officially Arrived
Finding a good deal on Wall Street is increasingly difficult.
I’m Not Selling Bloom Energy Before Earnings. Here’s the 1 Number I’m Watching.
The SOFC system maker continues to benefit from the AI market’s breakneck growth.